Results of mitral valve repair with an adjustable annuloplasty ring 2 years after implantation
- 297 Downloads
We aimed to investigate the safety and medium-term durability of an adjustable mitral annuloplasty ring in patients undergoing surgery for mitral valve regurgitation. Forty-five patients requiring mitral valve repair were enrolled into this prospective, multicentre study between May 2012 and May 2013 in six hospitals in Europe and Israel. Study endpoints evaluated the performance and safety of the device assessed using inter-individual comparisons. Implantation was performed through a sternotomy in ten patients and mini-thoracotomy in 35 patients. The ring was adjusted after declamping and weaning from cardio-pulmonary bypass under echocardiographic guidance if the coaptation surface was not optimal, or in cases of residual mitral regurgitation. Follow-up was performed up to 2 years post-procedure. Mean age was 61 ± 12 years. Ring adjustment was performed in 71% of patients to optimise the results of mitral valve repair. Following the procedure, 11/45 patients (24%) who had had mild residual mitral regurgitation had no mitral regurgitation following ring adjustment. Two patients with severe mitral regurgitation post-procedure had mild regurgitation following ring adjustment. Coaptation length increased significantly after adjustment. One patient died before hospital discharge due to complications unrelated to the adjustable ring. One patient had to undergo re-operation at 39 days post-procedure due to endocarditis. At 2 years of follow-up, 78% of patients had no residual mitral regurgitation and 22% had mild residual mitral regurgitation. Adjustable mitral annuloplasty ring implantation was safe in all patients. Mitral valve repair with the adjustable ring was durable in all patients who reached 2 years follow-up.
Clinical Trial Registration
KeywordsMitral regurgitation Mitral valve annuloplasty
We thank Anne Gale of the Deutsches Herzzentrum Berlin for editorial assistance. This work was supported by Valtech Cardio Ltd.
Compliance with ethical standards
Conflict of interest
O.A. is a minor stock holder of Valtech Cardio, F.M. is stock holder and consultant for Valtech cardio, V.F. is a consultant for Valtech Cardio, all other authors declare no conflict of interest.
Supplementary material 1 Video 1: Video animation of the device and the procedure. (MPG 29104 kb)
- 3.Maisano F, Falk V, Borger MA, Vanermen H, Alfieri O, Seeburger J, Jacobs S, Mack M, Mohr FW (2013) Improving mitral valve coaptation with adjustable rings: outcomes from a European multicentre feasibility study with a new-generation adjustable annuloplasty ring system. Eur J Cardiothorac Surg 44:913–918CrossRefPubMedGoogle Scholar
- 4.Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS); Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 42:S1–S44CrossRefPubMedGoogle Scholar
- 5.Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW (2008) Councils of the American Association for Thoracic Surgery; Society of Thoracic Surgeons; European Association for Cardio-Thoracic Surgery; Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 135:732–738CrossRefPubMedGoogle Scholar
- 8.Carpentier A, Adams DH, Filsoufi F (2010) Carpentier’s reconstructive valve surgery. Saunders Elsevier, Maryland Heights, pp 1–386Google Scholar
- 9.Ender J, Eibel S, Mukherjee C, Mathioudakis D, Borger MA, Jacobs S, Mohr FW, Falk V (2011) Prediction of the annuloplasty ring size in patients undergoing mitral valve repair using real-time three-dimensional transoesophageal echocardiography. Eur J Echocardiogr 12:445–453PubMedPubMedCentralGoogle Scholar
- 10.Rizza A, Sulcaj L, Glauber M, Trianni G, Palmieri C, Mariani M, Maffei S, Berti S (2007) Predictive value of less than moderate residual mitral regurgitation as assessed by transesophageal echocardiography for the short-term outcomes of patients with mitral regurgitation treated with mitral valve repair. Cardiovasc Ultrasound 5:25CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Andreas M, Doll N, Livesey S, Castella M, Kocher A, Casselman F, Voth V, Bannister C, Encalada Palacios JF, Pereda D, Laufer G, Czesla M (2016) Safety and feasibility of a novel adjustable mitral annuloplasty ring: a multicentre European experience. Eur J Cardiothorac Surg 49:249–254CrossRefPubMedGoogle Scholar